1141781-75-0Relevant academic research and scientific papers
4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF
-
Paragraph 00191, (2016/09/22)
Substituted benzoxaboroles whose structure comprises Formula (III), wherein R3 is selected from –CH3, –CH2CH3, –CH2=CH2, –CH2CH2CH3, –CH(CH3)sub
TRICYCLIC BENZOXABOROLE COMPOUNDS AND USES THEREOF
-
Paragraph 00157-00158, (2015/02/25)
Compounds of Formula II wherein X is selected from chloro, fluoro, bromo and iodo, R1 and R2 are each independently selected from H, -CH3, -CH2CH3, -CH2CH2CH3, or -CH(CH3)2
HETEROCYCLYL PYRAZOLOPYRIMIDINE ANALOGUES AS JAK INHIBITORS
-
Page/Page column 151, (2011/05/06)
The present invention relates to compounds of formula (I) wherein X1 to X5, Y, Z1 to Z3, and R have the meaning as cited in the description and the claims. Said compounds are useful as JAK inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments.
ALKOXY COMPOUNDS FOR DISEASE TREATMENT
-
Page/Page column 248, (2009/05/29)
The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these compounds. The subject compositions are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.
